Cargando…
A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease
Patients with type 1 Gaucher disease (GD1) present thrombocytopenia, anemia, organomegaly, and bone complications. Most experts consider that the less aggressive forms do not require specific treatment. However, little is known about the disease course of these forms. The objective of this cross-sec...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464688/ https://www.ncbi.nlm.nih.gov/pubmed/32708003 http://dx.doi.org/10.3390/jcm9082343 |
_version_ | 1783577420836634624 |
---|---|
author | Serratrice, Christine Stirnemann, Jérôme Berrahal, Amina Belmatoug, Nadia Camou, Fabrice Caillaud, Catherine Billette de Villemeur, Thierry Dalbies, Florence Cador, Bérengère Froissart, Roseline Masseau, Agathe Brassier, Anaïs Hivert, Bénédicte Swiader, Laure Bertchansky, Ivan de Moreuil, Claire Chabrol, Brigitte Durieu, Isabelle Leguy Seguin, Vanessa Astudillo, Leonardo Humbert, Sébastien Pichard, Samia Marcel, Catherine Hau Rainsard, Isabelle Bengherbia, Monia Yousfi, Karima Berger, Marc G. |
author_facet | Serratrice, Christine Stirnemann, Jérôme Berrahal, Amina Belmatoug, Nadia Camou, Fabrice Caillaud, Catherine Billette de Villemeur, Thierry Dalbies, Florence Cador, Bérengère Froissart, Roseline Masseau, Agathe Brassier, Anaïs Hivert, Bénédicte Swiader, Laure Bertchansky, Ivan de Moreuil, Claire Chabrol, Brigitte Durieu, Isabelle Leguy Seguin, Vanessa Astudillo, Leonardo Humbert, Sébastien Pichard, Samia Marcel, Catherine Hau Rainsard, Isabelle Bengherbia, Monia Yousfi, Karima Berger, Marc G. |
author_sort | Serratrice, Christine |
collection | PubMed |
description | Patients with type 1 Gaucher disease (GD1) present thrombocytopenia, anemia, organomegaly, and bone complications. Most experts consider that the less aggressive forms do not require specific treatment. However, little is known about the disease course of these forms. The objective of this cross-sectional retrospective study was to compare the clinical, radiological, and laboratory characteristics of patients with less severe GD1 at diagnosis and at the last evaluation to identify features that might lead to potential complications. Non-splenectomized and never-treated patients (19 women and 17 men) were identified in the French Gaucher Disease Registry (FGDR). Their median age was 36.6 years (2.4–75.1), and their median follow-up was 7.8 years (0.4–32.4). Moreover, 38.7% were heterozygous for the GBA1 N370S variant, and 22.6% for the GBA1 L444P variant. From diagnosis to the last evaluation, GD1 did not worsen in 75% of these patients. Some parameters improved (fatigue and hemoglobin concentration), whereas platelet count and chitotriosidase level remained stable. In one patient (2.7%), Lewy body dementia was diagnosed at 46 years of age. Bone lesion onset was late and usually a single event in most patients. This analysis highlights the genotypic heterogeneity of this subgroup, in which disease could remain stable and even improve spontaneously. It also draws attention to the possible risk of Lewy body disease and late onset of bone complications, even if isolated, to be confirmed in larger series and with longer follow-up. |
format | Online Article Text |
id | pubmed-7464688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74646882020-09-04 A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease Serratrice, Christine Stirnemann, Jérôme Berrahal, Amina Belmatoug, Nadia Camou, Fabrice Caillaud, Catherine Billette de Villemeur, Thierry Dalbies, Florence Cador, Bérengère Froissart, Roseline Masseau, Agathe Brassier, Anaïs Hivert, Bénédicte Swiader, Laure Bertchansky, Ivan de Moreuil, Claire Chabrol, Brigitte Durieu, Isabelle Leguy Seguin, Vanessa Astudillo, Leonardo Humbert, Sébastien Pichard, Samia Marcel, Catherine Hau Rainsard, Isabelle Bengherbia, Monia Yousfi, Karima Berger, Marc G. J Clin Med Article Patients with type 1 Gaucher disease (GD1) present thrombocytopenia, anemia, organomegaly, and bone complications. Most experts consider that the less aggressive forms do not require specific treatment. However, little is known about the disease course of these forms. The objective of this cross-sectional retrospective study was to compare the clinical, radiological, and laboratory characteristics of patients with less severe GD1 at diagnosis and at the last evaluation to identify features that might lead to potential complications. Non-splenectomized and never-treated patients (19 women and 17 men) were identified in the French Gaucher Disease Registry (FGDR). Their median age was 36.6 years (2.4–75.1), and their median follow-up was 7.8 years (0.4–32.4). Moreover, 38.7% were heterozygous for the GBA1 N370S variant, and 22.6% for the GBA1 L444P variant. From diagnosis to the last evaluation, GD1 did not worsen in 75% of these patients. Some parameters improved (fatigue and hemoglobin concentration), whereas platelet count and chitotriosidase level remained stable. In one patient (2.7%), Lewy body dementia was diagnosed at 46 years of age. Bone lesion onset was late and usually a single event in most patients. This analysis highlights the genotypic heterogeneity of this subgroup, in which disease could remain stable and even improve spontaneously. It also draws attention to the possible risk of Lewy body disease and late onset of bone complications, even if isolated, to be confirmed in larger series and with longer follow-up. MDPI 2020-07-22 /pmc/articles/PMC7464688/ /pubmed/32708003 http://dx.doi.org/10.3390/jcm9082343 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Serratrice, Christine Stirnemann, Jérôme Berrahal, Amina Belmatoug, Nadia Camou, Fabrice Caillaud, Catherine Billette de Villemeur, Thierry Dalbies, Florence Cador, Bérengère Froissart, Roseline Masseau, Agathe Brassier, Anaïs Hivert, Bénédicte Swiader, Laure Bertchansky, Ivan de Moreuil, Claire Chabrol, Brigitte Durieu, Isabelle Leguy Seguin, Vanessa Astudillo, Leonardo Humbert, Sébastien Pichard, Samia Marcel, Catherine Hau Rainsard, Isabelle Bengherbia, Monia Yousfi, Karima Berger, Marc G. A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease |
title | A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease |
title_full | A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease |
title_fullStr | A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease |
title_full_unstemmed | A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease |
title_short | A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease |
title_sort | cross-sectional retrospective study of non-splenectomized and never-treated patients with type 1 gaucher disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464688/ https://www.ncbi.nlm.nih.gov/pubmed/32708003 http://dx.doi.org/10.3390/jcm9082343 |
work_keys_str_mv | AT serratricechristine acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT stirnemannjerome acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT berrahalamina acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT belmatougnadia acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT camoufabrice acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT caillaudcatherine acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT billettedevillemeurthierry acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT dalbiesflorence acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT cadorberengere acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT froissartroseline acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT masseauagathe acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT brassieranais acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT hivertbenedicte acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT swiaderlaure acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT bertchanskyivan acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT demoreuilclaire acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT chabrolbrigitte acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT durieuisabelle acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT leguyseguinvanessa acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT astudilloleonardo acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT humbertsebastien acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT pichardsamia acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT marcelcatherine acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT haurainsardisabelle acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT bengherbiamonia acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT yousfikarima acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT bergermarcg acrosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT serratricechristine crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT stirnemannjerome crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT berrahalamina crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT belmatougnadia crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT camoufabrice crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT caillaudcatherine crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT billettedevillemeurthierry crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT dalbiesflorence crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT cadorberengere crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT froissartroseline crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT masseauagathe crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT brassieranais crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT hivertbenedicte crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT swiaderlaure crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT bertchanskyivan crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT demoreuilclaire crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT chabrolbrigitte crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT durieuisabelle crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT leguyseguinvanessa crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT astudilloleonardo crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT humbertsebastien crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT pichardsamia crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT marcelcatherine crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT haurainsardisabelle crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT bengherbiamonia crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT yousfikarima crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease AT bergermarcg crosssectionalretrospectivestudyofnonsplenectomizedandnevertreatedpatientswithtype1gaucherdisease |